Mycophenolate sodium does not reduce the incidence of GI adversed events compared with mycophenolate mofetil [2]

American Journal of Transplantation

Volumn 5, Issue 5, 2005, Pages 1164-

  Meier Kriesche, Herwig Ulf ^a   Davies, Neal M ^b   Grinyó, Josep ^c   Heading, Robert ^d   Mamelok, Richard ^e   Wijngaard, Peter ^e   Oellerich, Michael ^f   Maes, Bart ^g  

^a UNIVERSITY OF FLORIDA   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

DELAYED RELEASE FORMULATION; DRUG CAPSULE; DRUG INDUSTRY; GASTROINTESTINAL TOXICITY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; ORGAN TRANSPLANTATION; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; TABLET FORMULATION; UNITED STATES;

CLINICAL TRIALS; GASTROINTESTINAL TRACT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; RESEARCH DESIGN;

EID: 17644413799     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00778.x     Document Type: Letter

References (5)

1. Budde K, Curtis J, Knoll G et al. Enteric coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study. Am J Transplant 2004; 4: 237-243.
2. Salvadori M, Holzer H, de Mattos A et al. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 2004; 4: 231-236.
3. Curtis JJ, Kaplan B. Transplant immunosuppressive drug trials on trial. Am J Transplant 2004; 4: 671-672.
4. Fritsche L, Einecke G, Fleiner F, Dragun D, Neumayer HH, Budde K. Reports of large immunosuppression trials in kidney transplantation: room for improvement. Am J Transplant 2004; 4: 738-743.
5. Pescovitz MD, Conti D, Dunn J et al. Intravenous mycophenolate mofetil: safety, tolerabifity, and pharmacokinetics. Clin Transplantation 2000; 14: 179-188.